Helicobacter pylori: immer suchen, immer behandeln?

Zusammenfassung

Nach derzeitigem Kenntnisstand ist die Helicobacter-pylori-Infektion der primäre Trigger und wichtigsten Risikofaktor für die Magenkarzinogenese. Bei besonderen Risikogruppen und in Regionen mit hohem Risiko in der Allgemeinbevölkerung sind Screening-Strategien empfohlen und zum Teil implementiert. Eine generelle Screening-Strategie in der Allgemeinbevölkerung ist grundsätzlich zu begrüßen und könnte die nach wie vor hohe Last des Magenkarzinoms in der allgemeinen Bevölkerung und das Leid persönlicher Schicksale signifikant reduzieren.

Abstract

Current evidence assigns to the Helicobacter pylori infection an essential role and major risk in gastric carcinogenesis. In high risk groups and populations a H. pylori screen-and-treat strategy is recommended and already implemented in some countries. A general screen-and-treat is the way to go as it may reduce the burden of gastric cancer for the community and prevent deleterious individual destinies.

Schlüsselwörter

Helicobacter pylori - Eradikation - Screening

Keywords

Helicobacter pylori - eradication - screen-and-treat

• Literatur

• 1 Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134: 306-323
• 2 Bornschein J, Leja M, Kupcinskas J et al. Molecular diagnostics in gastric cancer. Front Biosci (Landmark Ed.) 2014; 19: 312-338
• 3 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg 2011; 8: 581-588
• 4 Bornschein J, Selgrad M, Warnecke M et al. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci 2010; 55: 3124-3131
• 5 Brenner H, Arndt V, Stegmaier C et al. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?. Am J Epidemiol 2004; 159: 252-258
• 6 Correa P. Gastric cancer: overview. Gastroenterol Clin North Am 2013; 42: 211-217
• 7 De Angelis R, Sant M, Coleman MP et al. EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 23-34
• 8 Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94
• 9 Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
• 10 Ekström AM, Held M, Hansson LE et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791
• 11 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403
• 12 Fischbach W, Malfertheiner P, Hoffmann JC et al. 4. S3-guideline "helicobacter pylori and gastroduodenal ulcer disease". Z Gastroenterol 2009; 47: 1230-1263
• 13 Fock KM, Katelaris P, Sugano K et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 10: 1587-1600
• 14 Franceschi F, Zuccalà G, Roccarina D et al. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2013;
• 15 Fuccio L, Zagari RM, Eusebi LH et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009; 151: 121-128
• 16 González CA, Sala N, Rokkas T. Gastric cancer: epidemiologic aspects. Helicobacter 2013; 18 (Suppl. 01) 34-38
• 17 Hamashima C, Shibuya D, Yamazaki H et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-267
• 18 Hosokawa O, Miyanaga T, Kaizaki Y et al. Decreased death from gastric cancer registry. Scand J Gastroenterol 2008; 43: 1112-1115
• 19 IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Biological agents. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100: 1-441
• 20 Lansdorp-Vogelaar I, Sharp L. Cost effectiveness of screening and treating H. pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol 2013; 27: 933-947
• 21 Lee KS, Oh DK, Han MA et al. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat 2011; 43: 83-88
• 22 Lee YC et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2013; 62: 676
• 23 Ma JL, Zhang L, Brown L et al. Fifteen-Year effects of H. pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Nat Cancer Inst 2012; 104: 488-492
• 24 Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009; 374: 1449-1461
• 25 Malfertheiner P, Megraud F, O'Morain CA et al. European Helicobacter Study Group. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664
• 26 Malfertheiner P, Sipponen P, Naumann M et al. H. pylori-Gastric Cancer Task Force. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005; 100: 2100-2115
• 27 Malfertheiner P. The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer. Dig Dis 2011; 29: 459-464
• 28 Miki K, Fujishiro M, Kodashima S et al. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc 2009; 21: 78-81
• 29 Ruskoné-Fourmestraux A, Fischbach W, Aleman BM et al. EGILS group. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011; 60: 747-758
• 30 Wong BC, Lam SK, Wong WM et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. JAMA 2004; 291: 187-194
• 31 Wrableski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010; 23: 713-739